Search clinical trials for: Hematological Malignancy

Total 1828 results

SCRI Development Innovations, LLC
Novartis

Completed

PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies

Advanced Malignancies | Refractory Malignancy

United States
University of Pittsburgh
Monash University

Completed

Towards Reducing Resistance and Hematological Toxicity of Linezolid

Infection | Adverse Effects

United States
Synta Pharmaceuticals Corp.

Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Lymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid Tumors

United States
University of Oklahoma

Completed

Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

Tumors | Lymphomas

United States
Amgen

Completed

Anemia in Patients With a Non-Myeloid Malignancy

Neoplasms | Anemia
Abbott
National Cancer Institute (NCI)

Completed

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
University of Padova

Completed

Screening for Occult Malignancy in Idiopathic Venous Thromboembolism

Venous Thromboembolism

Italy
AmpliMed Corporation

Completed

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy

Neoplasms

United States
National Human Genome Research Institute (NHGRI)

Completed

Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Prostatic Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

Hairy Cell Leukemia

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Brain Neoplasms | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

Glioma | Sarcoma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Lymphoma | Myelodysplastic Syndromes | Myeloid Leukemia | Hematologic Neoplasms | Graft vs Host Disease

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Intrathecal Topotecan

Lymphoma | Leukemia | Meningeal Neoplasms

United States
Millennium Pharmaceuticals, Inc.

Completed

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Amgen

Completed

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

Anemia
University Of Perugia

Unknown

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

Hematological Malignancies

Italy
Charite University, Berlin, Germany

Unknown

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Allogeneic Stem Cell Transplantation | Malignancy

Germany
Recoly N.V.

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

Haemophilia A

Russian Federation
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

Hematologic Neoplasms

United States, Canada
Hospices Civils de Lyon

Unknown

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Hematological Malignancies | Allogeneic Transplantation

France
Ziv Hospital

Unknown

Early Detection of Prostate Cancer by FACS (FACS)

Hyperplasia | Prostate Cancer

Israel
National Cancer Center, Korea

Unknown

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy (TIROX)

Colorectal Neoplasm | Secondary | Gastric Neoplasm

Korea, Republic of
Community Cancer Care
Amgen

Unknown

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Cancer | Solid Tumor | Hematologic Malignancy

United States
National Taiwan University Hospital

Completed

Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis

Lung Cancer
Sandoz

Completed

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

HIV Infections | Cytopenias

United States

3

Subscribe